MELANOMA IN 2013 Melanoma-the run of success continues
NATURE REVIEWS CLINICAL ONCOLOGY (2014)
期刊
NATURE REVIEWS CLINICAL ONCOLOGY
卷 11, 期 2, 页码 75-76出版社
NATURE PUBLISHING GROUP
关键词
类别
作者
我是这篇论文的作者
推荐
A hard-won success - but the work continues
Mark Little
VETERINARY RECORD (2023)
Search for effective treatments in patients with advanced refractory melanoma continues: can novel intratumoral therapies deliver?
Yana G. Najjar
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)
MAP kinase signaling and inhibition in melanoma (vol 32, pg 2373, 2013)
R. J. Sullivan, K. Flaherty
ONCOGENE (2021)
Keeping the Competitive Edge of a Convention and Exhibition Center in MICE Environment: Identification of Event Attributes for Long-Run Success
Jaeyoung An, Hany Kim, Dongkeun Hur
SUSTAINABILITY (2021)
Invertebrate biodiversity continues to decline in cropland
Francesca Mancini, Rob Cooke, Ben A. A. Woodcock, Arran Greenop, Andrew C. C. Johnson, Nick J. B. Isaac
PROCEEDINGS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2023)
Disease Burden of the Kidney Disabled in Korea, 2009-2013: The Gap with That of the Non-Kidney Disabled Continues
Sun-Mi Shin, Hee-Woo Lee
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2022)
Low von Willebrand factor phenotype: the enigma continues
David Lillicrap
BLOOD (2022)
Careful what you say: The effect of manipulative information on the 2013 Czech presidential run-off election
Martin Guzi, Stepan Mikula
ECONOMICS LETTERS (2021)
Diagnosis of gestational diabetes mellitus: the debate continues
Aoife M. Egan, Fidelma P. Dunne
NATURE REVIEWS ENDOCRINOLOGY (2022)
Geographies of run-commuting in the UK
Simon Cook
JOURNAL OF TRANSPORT GEOGRAPHY (2021)
A Bibliometric Analysis of Melanoma Treated with Vaccinations Research from 2013 to 2023: A Comprehensive Review of the Literature
Xinyu Wang, Qian-Nan Jia, Mengyin Wu, Mingjuan Liu, Jun Li
VACCINES (2023)
Glycemic Control and the Heart: The Tale of Diabetic Cardiomyopathy Continues
Miriam Longo, Lorenzo Scappaticcio, Paolo Cirillo, Antonietta Maio, Raffaela Carotenuto, Maria Ida Maiorino, Giuseppe Bellastella, Katherine Esposito
BIOMOLECULES (2022)
The control of soil-transmitted helminthiases in the Philippines: the story continues
Mary Lorraine S. Mationg, Veronica L. Tallo, Gail M. Williams, Catherine A. Gordon, Archie C. A. Clements, Donald P. McManus, Darren J. Gray
INFECTIOUS DISEASES OF POVERTY (2021)
The undifferentiated arthritis dilemma: the story continues
Daniel Aletaha
NATURE REVIEWS RHEUMATOLOGY (2022)
Infectious etiology and amyloidosis in Alzheimer's disease: The puzzle continues
Rakez Kayed
JOURNAL OF BIOLOGICAL CHEMISTRY (2021)
Reply to: Letter comments on: Pyrexia in patients treated with dabrafenib plus trametinib across clinical trials in BRAF-mutant cancers
Dirk Schadendorf
EUROPEAN JOURNAL OF CANCER (2022)
Long-Term Outcomes With Nivolumab Plus Ipilimumab or Nivolumab Alone Versus Ipilimumab in Patients With Advanced Melanoma
Jedd D. Wolchok, Vanna Chiarion-Sileni, Rene Gonzalez, Jean-Jacques Grob, Piotr Rutkowski, Christopher D. Lao, C. Lance Cowey, Dirk Schadendorf, John Wagstaff, Reinhard Dummer, Pier Francesco Ferrucci, Michael Smylie, Marcus O. Butler, Andrew Hill, Ivan Marquez-Rodas, John B. A. G. Haanen, Massimo Guidoboni, Michele Maio, Patrick Schoffski, Matteo S. Carlino, Celeste Lebbe, Grant McArthur, Paolo A. Ascierto, Gregory A. Daniels, Georgina Long, Tuba Bas, Corey Ritchings, James Larkin, F. Stephen Hodi
JOURNAL OF CLINICAL ONCOLOGY (2022)
Adjuvant Therapy of Nivolumab Combined With Ipilimumab Versus Nivolumab Alone in Patients With Resected Stage IIIB-D or Stage IV Melanoma (CheckMate 915)
Jeffrey S. Weber, Dirk Schadendorf, Michele Del Vecchio, James Larkin, Victoria Atkinson, Michael Schenker, Jacopo Pigozzo, Helen Gogas, Stephane Dalle, Nicolas Meyer, Paolo A. Ascierto, Shahneen Sandhu, Thomas Eigentler, Ralf Gutzmer, Jessica C. Hassel, Caroline Robert, Matteo S. Carlino, Anna Maria Di Giacomo, Marcus O. Butler, Eva Munoz-Couselo, Michael P. Brown, Piotr Rutkowski, Andrew Haydon, Jean-Jacques Grob, Jacob Schachter, Paola Queirolo, Luis de la Cruz-Merino, Andrew Haydon, Jean-Jacques Grob, Jacob Schachter, Paola Queirolo, Luis De La Cruz-Merino, Andre van der Westhuizen, Alexander M. Menzies, Sandra Re, Tuba Bas, Veerle de Pril, Julia Braverman, Daniel J. Tenney, Hao Tang, Georgina Long
JOURNAL OF CLINICAL ONCOLOGY (2023)
Multimodal integration of image, epigenetic and clinical data to predict BRAF mutation status in melanoma
Lucas Schneider, Christoph Wies, Eva I. Krieghoff-Henning, Tabea-Clara Bucher, Jochen S. Utikal, Dirk Schadendorf, Titus J. Brinker
EUROPEAN JOURNAL OF CANCER (2023)
Alternatives and reduced need for sentinel lymph node biopsy (SLNB) staging for melanoma
Alexander C. J. van Akkooi, Dirk Schadendorf, Alexander M. M. Eggermont
EUROPEAN JOURNAL OF CANCER (2023)
Multispectral optoacoustic tomography to differentiate between lymph node metastases and coronavirus-19 vaccine-associated lymphadenopathy
Jan-Malte Placke, Delphine Mertens, Alpaslan Tasdogan, Eleftheria Chorti, Dirk Schadendorf, Selma Ugurel, Alexander Roesch, Ingo Stoffels, Joachim Klode
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2023)
Changes in body mass index, weight, and waist-to-hip ratio over five years in HIV-positive individuals in the HIV Heart Aging Study compared to the general population
Laven Mavarani, Sarah Albayrak-Rena, Anja Potthoff, Martin Hower, Sebastian Dolff, Stefanie Sammet, Felix Maischack, Dirk Schadendorf, Boerge Schmidt, Stefan Esser
INFECTION (2023)
Initial Evidence for the Efficacy of Naporafenib in Combination With Trametinib in NRAS-Mutant Melanoma: Results From the Expansion Arm of a Phase Ib, Open-Label Study
Filippo de Braud, Christophe Dooms, Rebecca S. Heist, Celeste Lebbe, Martin Wermke, Anas Gazzah, Dirk Schadendorf, Piotr Rutkowski, Juergen Wolf, Paolo A. Ascierto, Ignacio Gil-Bazo, Shumei Kato, Maria Wolodarski, Meredith McKean, Eva Munoz Couselo, Martin Sebastian, Armando Santoro, Vesselina Cooke, Luca Manganelli, Kitty Wan, Anil Gaur, Jaeyeon Kim, Giordano Caponigro, Xuan-Mai Couillebault, Helen Evans, Catarina D. Campbell, Sumit Basu, Michele Moschetta, Adil Daud
JOURNAL OF CLINICAL ONCOLOGY (2023)
Nivolumab and Relatlimab in Patients With Advanced Melanoma That Had Progressed on Anti-Programmed Death-1/Programmed Death Ligand 1 Therapy: Results From the Phase I/IIa RELATIVITY-020 Trial
Paolo Antonio Ascierto, Evan J. Lipson, Reinhard Dummer, James Larkin, Georgina V. Long, Rachel E. Sanborn, Vanna Chiarion-Sileni, Brigitte Dreno, Stephane Dalle, Dirk Schadendorf, Margaret K. Callahan, Marta Nyakas, Victoria Atkinson, Carlos Alberto Gomez-Roca, Naoya Yamazaki, Hussein A. Tawbi, Naomey Sarkis, Deepti Warad, Sonia Dolfi, Priyam Mitra, Satyendra Suryawanshi, Jean-Jacques Grob
JOURNAL OF CLINICAL ONCOLOGY (2023)
Health-related quality of life with nivolumab plus relatlimab versus nivolumab monotherapy in patients with previously untreated unresectable or metastatic melanoma: RELATIVITY-047 trial
Dirk Schadendorf, Hussein Tawbi, Evan J. Lipson, F. Stephen Hodi, Piotr Rutkowski, Helen Gogas, Christopher D. Lao, Jean-Jacques Grob, Andriy Moshyk, Jennifer Lord-Bessen, Melissa Hamilton, Shien Guo, Ling Shi, Sarah Keidel, Georgina Long
EUROPEAN JOURNAL OF CANCER (2023)
Deep learning detection of melanoma metastases in lymph nodes
Philipp Jansen, Daniel Otero Baguer, Nicole Duschner, Jean Le'Clerc Arrastia, Maximilian Schmidt, Jennifer Landsberg, Joerg Wenzel, Dirk Schadendorf, Eva Hadaschik, Peter Maass, Joerg Schaller, Klaus Georg Griewank
EUROPEAN JOURNAL OF CANCER (2023)
COMBI-r: A Prospective, Non-Interventional Study of Dabrafenib Plus Trametinib in Unselected Patients with Unresectable or Metastatic BRAF V600-Mutant Melanoma
Carola Berking, Elisabeth Livingstone, Dirk Debus, Carmen Loquai, Michael Weichenthal, Ulrike Leiter, Felix Kiecker, Peter Mohr, Thomas K. Eigentler, Janina Remy, Katharina Schober, Markus V. Heppt, Imke von Wasielewski, Dirk Schadendorf, Ralf Gutzmer
CANCERS (2023)
Systemic LRG1 Expression in Melanoma is Associated with Disease Progression and Recurrence
Esmee P. Hoefsmit, Franziska Vollmy, Elisa A. Rozeman, Irene L. M. Reijers, Judith M. Versluis, Liesbeth Hoekman, Alexander C. J. van Akkooi, Georgina Long, Dirk Schadendorf, Reinhard Dummer, Maarten Altelaar, Christian U. Blank
CANCER RESEARCH COMMUNICATIONS (2023)
Deep learning based histological classification of adnex tumors
Philipp Jansen, Jean Le 'Clerc Arrastia, Daniel Otero Baguer, Maximilian Schmidt, Jennifer Landsberg, Joerg Wenzel, Michael Emberger, Dirk Schadendorf, Eva Hadaschik, Peter Maass, Klaus Georg Griewank
EUROPEAN JOURNAL OF CANCER (2024)
Contribution of MEK Inhibition to BRAF/MEK Inhibitor Combination Treatment of BRAF-Mutant Melanoma: Part 2 of the Randomized, Open-Label, Phase III COLUMBUS Trial
Paolo A. Ascierto, Reinhard Dummer, Helen J. Gogas, Ana Arance, Mario Mandala, Gabriella Liszkay, Claus Garbe, Dirk Schadendorf, Ivana Krajsova, Ralf Gutzmer, Vanna Chiarion-Sileni, Caroline Dutriaux, Jan Willem B. de Groot, Naoya Yamazaki, Carmen Loquai, Caroline Robert, Keith T. Flaherty
JOURNAL OF CLINICAL ONCOLOGY (2023)